PRMT5 inhibition impairs Fanconi Anemia pathway-mediated homologous recombination and enhances the antitumor efficacy of Temozolomide in glioblastoma
Shumpei Onishi, Sridharan Jayamohan, Ashis Chowdhury, Sarah Rivas et autres
us (code pays fourni par la source)